HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriyuki Miyoshi Selected Research

secosterol-B

3/2018Biochemical properties of cholesterol aldehyde secosterol and its derivatives.
1/2012Inhibition of endothelial- and neuronal-type, but not inducible-type, nitric oxide synthase by the oxidized cholesterol metabolite secosterol aldehyde: Implications for vascular and neurodegenerative diseases.
9/2011A highly sensitive LC-ESI-MS/MS method for the quantification of cholesterol ozonolysis products secosterol-A and secosterol-B after derivatization with 2-hydrazino-1-methylpyridine.
1/2011Formation of cholesterol ozonolysis products in vitro and in vivo through a myeloperoxidase-dependent pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriyuki Miyoshi Research Topics

Disease

14Neoplasms (Cancer)
06/2022 - 03/2002
12Carcinogenesis
01/2021 - 01/2004
9Inflammation (Inflammations)
02/2021 - 04/2004
6Atherosclerosis
01/2020 - 01/2011
6Obesity
05/2018 - 10/2011
5Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2019
5Neurodegenerative Diseases (Neurodegenerative Disease)
05/2018 - 01/2011
4Carcinoma (Carcinomatosis)
01/2021 - 10/2011
3Atherosclerotic Plaque (Atheroma)
01/2020 - 03/2018
3Alzheimer Disease (Alzheimer's Disease)
05/2018 - 09/2011
3Leukemia
01/2012 - 04/2002
3Necrosis
10/2008 - 03/2002
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 01/2020
2Breast Neoplasms (Breast Cancer)
02/2021 - 09/2014
2Body Weight (Weight, Body)
01/2021 - 06/2011
2Colonic Neoplasms (Colon Cancer)
08/2017 - 10/2012
2Hepatocellular Carcinoma (Hepatoma)
09/2011 - 04/2011
1Neoplasm Metastasis (Metastasis)
02/2021
1Lymphatic Metastasis
02/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Adenocarcinoma
11/2020
1Lung Neoplasms (Lung Cancer)
10/2020
1Warts (Wart)
06/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2020
1Infections
01/2020
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2020
1Hearing Loss (Hearing Impairment)
01/2020
1Hyperplasia
01/2019
1Hemorrhage
01/2019
1Memory Disorders (Memory Loss)
05/2018
1Parkinson Disease (Parkinson's Disease)
05/2018
1Cognitive Dysfunction
05/2018
1Dehydration (Water Stress)
03/2018
1Lewy Body Disease (Lewy Body Dementia)
03/2018
1Aberrant Crypt Foci
08/2017
1Intestinal Polyps
02/2016
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2016

Drug/Important Bio-Agent (IBA)

12TeaIBA
06/2022 - 07/2008
6colibactinIBA
03/2022 - 01/2019
5CholesterolIBA
03/2018 - 01/2011
4secosterol-BIBA
03/2018 - 01/2011
4benzyl isothiocyanateIBA
01/2012 - 03/2002
3CoffeeFDA Link
06/2022 - 10/2020
3Apolipoproteins E (ApoE)IBA
01/2021 - 11/2019
3ApolipoproteinsIBA
01/2021 - 11/2019
32-toluidine (o-toluidine)IBA
12/2020 - 01/2019
3AldehydesIBA
03/2018 - 01/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2017 - 11/2010
3EnzymesIBA
09/2012 - 04/2011
2PolyphenolsIBA
06/2022 - 03/2022
2MicroRNAs (MicroRNA)IBA
06/2022 - 03/2022
2QuercetinIBA
02/2021 - 09/2014
2Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2016
2DNA AdductsIBA
01/2021 - 01/2020
22-anisidine (o-anisidine)IBA
01/2021 - 01/2019
2AminesIBA
01/2021 - 01/2020
2AcetyltransferasesIBA
01/2021 - 01/2020
2Catechin (Z 7300)IBA
06/2020 - 04/2011
2Biological ProductsIBA
01/2020 - 04/2004
2AcidsIBA
01/2020 - 12/2004
2Proteins (Proteins, Gene)FDA Link
03/2018 - 11/2010
2AzoxymethaneIBA
08/2017 - 06/2011
2isothiocyanic acidIBA
06/2016 - 10/2012
2Interleukin-6 (Interleukin 6)IBA
02/2016 - 07/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 11/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2012 - 01/2012
2Drinking WaterIBA
09/2012 - 06/2011
2Oxidants (Oxidizing Agents)IBA
07/2011 - 07/2008
2CytokinesIBA
06/2011 - 02/2006
2CaspasesIBA
10/2008 - 03/2002
2DNA (Deoxyribonucleic Acid)IBA
07/2008 - 12/2004
2Caspase 3 (Caspase-3)IBA
09/2003 - 03/2002
1Indicators and Reagents (Reagents)IBA
02/2021
12- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2021
1Hemolysin Proteins (Hemolysins)IBA
11/2020
1Chlorogenic AcidIBA
10/2020
1stercobilinIBA
01/2020
1CarcinogensIBA
01/2020
1Lipoproteins (Lipoprotein)IBA
01/2020
1MutagensIBA
01/2020
1OligosaccharidesIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2020
1DystrophinIBA
01/2020
1Volatile Organic CompoundsIBA
01/2020
1PrebioticsIBA
01/2020
1PolyketidesIBA
01/2020
1LipidsIBA
11/2019
1MyokinesIBA
11/2019
1Apoptosis Regulatory ProteinsIBA
05/2018
1SynucleinsIBA
05/2018
1ScleroproteinsIBA
05/2018
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
01/2018
1phenethyl isothiocyanate (PEITC)IBA
01/2018
1LeptinIBA
01/2018
1Transcription Factors (Transcription Factor)IBA
08/2017
1LuciferasesIBA
08/2017
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2017
1Anticarcinogenic AgentsIBA
08/2017

Therapy/Procedure

1Transplantation
01/2020